Join
Live feed
·
INSIDERFilingvia Quantisnow
Context Therapeutics Inc. logo

Chief Financial Officer Minai-Azary Jennifer Lynn bought $25,486 worth of shares (40,010 units at $0.64), increasing direct ownership by 100% to 80,010 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CNTX· Context Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTX (Context Therapeutics Inc.) and more on Quantisnow.